Shanghai Fosun Current Valuation vs. EBITDA
| SFOSFDelisted Stock | USD 1.70 0.00 0.00% |
For Shanghai Fosun profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shanghai Fosun to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shanghai Fosun Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shanghai Fosun's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shanghai Fosun Pharmaceutical over time as well as its relative position and ranking within its peers.
Shanghai |
Shanghai Fosun Pharm EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Fosun's current stock value. Our valuation model uses many indicators to compare Shanghai Fosun value to that of its competitors to determine the firm's financial worth. Shanghai Fosun Pharmaceutical is currently regarded number one company in current valuation category among its peers. It also is currently regarded as top stock in ebitda category among its peers totaling about 0.56 of EBITDA per Current Valuation. The ratio of Current Valuation to EBITDA for Shanghai Fosun Pharmaceutical is roughly 1.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shanghai Fosun's earnings, one of the primary drivers of an investment's value.Shanghai Current Valuation vs. Competition
Shanghai Fosun Pharmaceutical is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 34.29 Billion. Shanghai Fosun totals roughly 15.52 Billion in current valuation claiming about 45% of equities under Drug Manufacturers—Specialty & Generic industry.
Shanghai EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Shanghai Fosun |
| = | 15.52 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Shanghai Fosun |
| = | 8.71 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Shanghai EBITDA Comparison
Shanghai Fosun is currently under evaluation in ebitda category among its peers.
Shanghai Fosun Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Shanghai Fosun, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shanghai Fosun will eventually generate negative long term returns. The profitability progress is the general direction of Shanghai Fosun's change in net profit over the period of time. It can combine multiple indicators of Shanghai Fosun, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Shanghai Fosun Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. Shanghai Fosun Pharmaceutical Co., Ltd. was founded in 1994 and is based in Shanghai, China. Shanghai Fosun operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 36604 people.
Shanghai Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Shanghai Fosun. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shanghai Fosun position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shanghai Fosun's important profitability drivers and their relationship over time.
Use Shanghai Fosun in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shanghai Fosun position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Fosun will appreciate offsetting losses from the drop in the long position's value.Shanghai Fosun Pair Trading
Shanghai Fosun Pharmaceutical Pair Trading Analysis
The ability to find closely correlated positions to Shanghai Fosun could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanghai Fosun when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanghai Fosun - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanghai Fosun Pharmaceutical to buy it.
The correlation of Shanghai Fosun is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shanghai Fosun moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shanghai Fosun Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shanghai Fosun can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Shanghai Fosun position
In addition to having Shanghai Fosun in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Shanghai Pink Sheet
If you are still planning to invest in Shanghai Fosun Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shanghai Fosun's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |